Literature DB >> 25870064

Factors associated with antibiotic misuse in outpatient treatment for upper respiratory tract infections.

Jennifer L Schroeck1, Christine A Ruh1, John A Sellick2, Michael C Ott3, Arun Mattappallil4, Kari A Mergenhagen5.   

Abstract

The Centers for Disease Control and Prevention has promoted the appropriate use of antibiotics since 1995 when it initiated the National Campaign for Appropriate Antibiotic Use in the Community. This study examined upper respiratory tract infections included in the campaign to determine the degree to which antibiotics were appropriately prescribed and subsequent admission rates in a veteran population. This study was a retrospective chart review conducted among outpatients with a diagnosis of a respiratory tract infection, including bronchitis, pharyngitis, sinusitis, or nonspecific upper respiratory tract infection, between January 2009 and December 2011. The study found that 595 (35.8%) patients were treated appropriately, and 1,067 (64.2%) patients received therapy considered inappropriate based on the Get Smart Campaign criteria. Overall the subsequent readmission rate was 1.5%. The majority (77.5%) of patients were prescribed an antibiotic. The most common antibiotics prescribed were azithromycin (39.0%), amoxicillin-clavulanate (13.2%), and moxifloxacin (7.5%). A multivariate regression analysis demonstrated significant predictors of appropriate treatment, including the presence of tonsillar exudates (odds ratio [OR], 0.6; confidence interval [CI], 0.3 to 0.9), fever (OR, 0.6; CI, 0.4 to 0.9), and lymphadenopathy (OR, 0.4; CI, 0.3 to 0.6), while penicillin allergy (OR, 2.9; CI, 1.7 to 4.7) and cough (OR, 1.6; CI, 1.1 to 2.2) were significant predictors for inappropriate treatment. Poor compliance with the Get Smart Campaign was found in outpatients for respiratory infections. Results from this study demonstrate the overprescribing of antibiotics, while providing a focused view of improper prescribing. This article provides evidence that current efforts are insufficient for curtailing inappropriate antibiotic use.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25870064      PMCID: PMC4468652          DOI: 10.1128/AAC.00652-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Excessive antibiotic use for acute respiratory infections in the United States.

Authors:  R Gonzales; D C Malone; J H Maselli; M A Sande
Journal:  Clin Infect Dis       Date:  2001-08-21       Impact factor: 9.079

2.  Dynamics of antibiotic prescribing for children.

Authors:  Michael E Pichichero
Journal:  JAMA       Date:  2002-06-19       Impact factor: 56.272

Review 3.  Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries.

Authors:  Benedikt Huttner; Herman Goossens; Theo Verheij; Stephan Harbarth
Journal:  Lancet Infect Dis       Date:  2010-01       Impact factor: 25.071

4.  Office-related antibiotic prescribing for persons aged ≤ 14 years--United States, 1993-1994 to 2007-2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-09-02       Impact factor: 17.586

5.  U.S. outpatient antibiotic prescribing, 2010.

Authors:  Lauri A Hicks; Thomas H Taylor; Robert J Hunkler
Journal:  N Engl J Med       Date:  2013-04-11       Impact factor: 91.245

6.  A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use.

Authors:  Carlene A Muto; Marian Pokrywka; Kathleen Shutt; Aaron B Mendelsohn; Kathy Nouri; Kathy Posey; Terri Roberts; Karen Croyle; Sharon Krystofiak; Sujata Patel-Brown; A William Pasculle; David L Paterson; Melissa Saul; Lee H Harrison
Journal:  Infect Control Hosp Epidemiol       Date:  2005-03       Impact factor: 3.254

7.  Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

Authors:  Melinda M Neuhauser; Robert A Weinstein; Robert Rydman; Larry H Danziger; George Karam; John P Quinn
Journal:  JAMA       Date:  2003-02-19       Impact factor: 56.272

8.  Impact of hospital formularies on fluoroquinolone prescribing in emergency departments.

Authors:  Sherrie L Aspinall; Joshua P Metlay; Judith H Maselli; Ralph Gonzales
Journal:  Am J Manag Care       Date:  2007-05       Impact factor: 2.229

9.  Effects of knowledge, attitudes, and practices of primary care providers on antibiotic selection, United States.

Authors:  Guillermo V Sanchez; Rebecca M Roberts; Alison P Albert; Darcia D Johnson; Lauri A Hicks
Journal:  Emerg Infect Dis       Date:  2014-12       Impact factor: 6.883

10.  Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes.

Authors:  Werner C Albrich; Dominique L Monnet; Stephan Harbarth
Journal:  Emerg Infect Dis       Date:  2004-03       Impact factor: 6.883

View more
  32 in total

1.  Reply to "Minimizing Antibiotic Misuse through Evidence-Based Management of Outpatient Acute Respiratory Infections".

Authors:  Jennifer L Schroeck; Christine A Ruh; John A Sellick; Michael C Ott; Arun Mattappallil; Kari A Mergenhagen
Journal:  Antimicrob Agents Chemother       Date:  2015-10       Impact factor: 5.191

2.  Minimizing Antibiotic Misuse through Evidence-Based Management of Outpatient Acute Respiratory Infections.

Authors:  Guillermo V Sanchez; Katherine E Fleming-Dutra; Lauri A Hicks
Journal:  Antimicrob Agents Chemother       Date:  2015-10       Impact factor: 5.191

3.  Training Student Pharmacists to Perform Point-of-Care Testing.

Authors:  Kimberly McKeirnan; Jennifer Czapinski; Taylor Bertsch; Christina Buchman; Julie Akers
Journal:  Am J Pharm Educ       Date:  2019-09       Impact factor: 2.047

4.  Pharmacologic management of voice disorders by general medicine providers and otolaryngologists.

Authors:  Seth M Cohen; Hui-Jie Lee; Nelson Roy; Stephanie Misono
Journal:  Laryngoscope       Date:  2017-09-25       Impact factor: 3.325

5.  Detection of group a Streptococcus in pharyngitis by two rapid tests: comparison of the BD Veritor™ and the QuikRead go® Strep A.

Authors:  Maya Azrad; Elena Danilov; Sivan Goshen; Orna Nitzan; Avi Peretz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-03-09       Impact factor: 3.267

6.  Patient and provider characteristics and outcomes associated with outpatient antibiotic overuse in acute adult bronchitis.

Authors:  Diana Li; Maricar Conson; Nina Kim; Marie Yasuda; Delaney Ivy; Sandy Diec; Paul Godley
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-02-03

7.  Rapid antigen test use for the management of group A streptococcal pharyngitis in community pharmacies.

Authors:  Béatrice Demoré; Gianpiero Tebano; Julien Gravoulet; Christophe Wilcke; Eric Ruspini; Jacques Birgé; Jean-Marc Boivin; Sandrine Hénard; Annick Dieterling; Lidiana Munerol; Julie Husson; Christian Rabaud; Céline Pulcini; Sophie Malblanc
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-06       Impact factor: 3.267

8.  Antibiotics and COPD: Time to order a C-reactive protein test?

Authors:  Cleveland Piggott; Corey Lyon
Journal:  J Fam Pract       Date:  2021-06       Impact factor: 0.493

9.  Regional variation in antibiotic prescribing among medicare part D enrollees, 2013.

Authors:  Andre Arizpe; Kelly R Reveles; Samuel L Aitken
Journal:  BMC Infect Dis       Date:  2016-12-09       Impact factor: 3.090

10.  Time trends in antibiotic consumption in the elderly: Ten-year follow-up of the Spanish National Health Survey and the European Health Interview Survey for Spain (2003-2014).

Authors:  Domingo Palacios-Ceña; Valentín Hernández-Barrera; Isabel Jiménez-Trujillo; Ramón Serrano-Urrea; César Fernández-de-Las-Peñas; Pilar Carrasco-Garrido
Journal:  PLoS One       Date:  2017-11-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.